CIIHY yields 2.85% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, CIIHY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CIIHY + JNJ for your $10,000?
CITIC Securities Company Limited provides various financial products and services in Mainland China and internationally. It operates through Investment Banking, Brokerage, Trading, Asset Management, and Others segments. The company offers investment banking services, including equity and debt financing, as well as fundraising and financial advisory services to a range of enterprises and other institutional clients. It is also involved in the broking of securities and futures; distribution of financial products; and trading and market-making of equity products, fixed income products and derivatives, foreign exchange, margin financing and securities lending, alternative investment, and commodities business. In addition, the company offers asset management services, such as collective asset management, specialized asset management, separately managed account, fund management, and other investment accounts management; private equity investment and other services; and custody and research services. Further, it provides institutional brokerage, investment advisory and management, investment consultancy, fiduciary management, fund, real estate, business training, and financial products and securities investment services. Additionally, the company offers finance outsourcing, bond issuance, offshore portfolio hedge and investment fund, fund distribution, leveraged foreign exchange and other transactions, investment with self-owned capital, cash transactions, property management and leasing, and other services. It also engages in information technology development, technical consulting, research and development of financial products, portfolio design, and consulting activities. CITIC Securities Company Limited was incorporated in 1995 and is based in Beijing, the People's Republic of China.
Full CIIHY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.